Feedback / Questions
ADS051 - Adiso Therap
https://www.prnewswire.com/news-releases/adiso-therapeutics-announces-data-publication-of-two-phase-1-studies-of-first-in-class-neutrophil-modulator-ads051-in-the-american-journal-of-gastroenterology-302393958.html
Mar 6, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next